Vitamin D and COVID-19.

George Trovas, Symeon Tournis

Hormones (Athens, Greece) 2021 Mar

filter terms:

all
compound
phenotype
FDA drugs
show more »
show less «

Epidemiological data report that several countries with a high prevalence of hypovitaminosis D may have increased susceptibility to complications and mortality due to COVID-19 infection. These reports, however, have limitations given that they derive from observational studies. Nevertheless, while awaiting more robust data, clinicians should treat patients with vitamin D deficiency irrespective of whether or not it has a link with respiratory infections.